#eauguidelines always pursuing how to evolve and be improved. Thank you to all panel chairs for their compromise, commitment and efforts to update our guidelines on yearly basis. Thank you to GO Board and staff for their dedication. A big team that teaches me everyday!!

Celebrating the incredible women of Weill Cornell Medicine Hematology & Oncology! Our #HemeOnc Women Physicians’ Group spring meeting was an enlightening & enriching experience. #WomeninMedicine Hematology & Oncology Women Physicians Group—HOWPG WCMHemOncFellow

What do you get when you combine expertise with innovation?
A #SinglePort RAPN by Simone Crivellaro from UIC Urology moderated by Dr. Jihad Kaouk and Aldo Brassetti, at our upcoming congress! Do not miss this unmissable edition of #CILR24

Fantastic for kidney cancer research!!!

🚨🇦🇺 DEADLY AIRBORNE VIRUS SPREADS IN AUSTRALIA

Australian authorities confirmed an infected passenger arrived at Melbourne airport on February 14, just days after the virus was first detected in Sydney.

Health official Dr. Clare Looker:
'Anyone who develops symptoms of

Exciting risk-adapted trial for adjuvant therapy in urothelial cancer. Able to be opened across the NCTN program!

Updated analysis showing ctDNA as potentially predictive and prognostic marker after cystectomy in muscle invasive bladder cancer. CtDNA clearance also looks important. New data on relapse rates in ctDNA-ve with be #EAU24 joaquim bellmunt European Urology

New research introduces a noninvasive method using cfDNA methylation signatures to accurately detect #neuroendocrine #prostate #cancer , highlighting the potential of methylation profiling in personalized medicine. #PrecisionMedicine #CancerTherapy #NEPC #Genomics .

WHO Global #Cancer Observatory just released it’s latest update. Explore incidence, mortality, & prevalence for 36 cancer types in 185 countries. You can also discover trends until 2050!. It is a fascinating website to explore. gco.iarc.fr/today/en

Dr. Eleni Andreopoulou (Eleni Andreopoulou, MD) spoke with Greek news outlet mononewsgr about #BreastCancer #research , treatment, screening, the aims of #PrecisionMedicine , and her personal perspective as a female physician: bit.ly/4bAZOAg (cc: WCM Englander Institute for Precision Medicine)

Hot off the press in ACS Journal Cancer: Plant‐based diet associated with better quality of life in #prostatecancer survivors in HPFS HT Scott Bauer Stacey Kenfield Alicia Morgans, MD, MPH June M. Chan Erin Van Blarigan Alaina Shreves Lorelei Mucci
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

#CILR24 You can't miss this!
The 20th edition , where it all began two decades ago, in the world's most beautiful city.
See you there! #20years #livesurgery #roboticsurgery #laparoscopy #urology

#CILR24 Early registration expires March 2nd!
Check the Program & join us in Rome!

Looking forward to my visit to Koch Institute at MIT Massachusetts Institute of Technology (MIT)
Thanks Francisco J. Sánchez-Rivera for the invitation

The WCM Englander Institute for Precision Medicine is a translational hub where we use #Genomics , #Al and technologies like high throughput sequencing & imaging mass cytometry to personalize medicine. #PrecisionMedicine #organoids #MixedReality

Watch our recent video and learn more!

Articles in Press: The Elusive Horizon: Biomarkers in Urothelial Carcinoma

buff.ly/3HWPTqZ

Lars Dyrskjøt Josh Linscott Roger Li Joshua Meeks

#UroSoMe #Medtwitter

An important anniversary for this meeting. We all await your data Toni, Cora Sternberg

VESPER Trial: survival endpoints at 5 years in an open-label, randomized, phase 3 study

Overall, ITT, in perioperative setting : no association of OS with dd-MVAC vs GC treatment (64% vs 56%, HR 0·79)

In the NAC subgroup: OS at 5 years improved in the dd-MVAC group (66% vs

Late 2023 drop of CYPIDES, a Ph I/II trial of a CYP11A1 inhibitor (ODM-208) that blocks steroid synthesis & is very active in AR mutant #prostatecancer - 53% PSA RR in ARPI-Rx pts. Major S/E: adrenal insufficiency

Provides a strong platform for coming OMAHA trials Merck

Bishoy M. Faltas, MD, was awarded the Society for Basic Urologic Research Young Investigator Award, granted to SBUR members under the age of 45, having significant contributions to #urologicresearch . ow.ly/jvsT50QkOYw Dr. Bishoy M. Faltas